comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 04:41:48 - browse：89459

Adam's take main illustration — Molly Ferguson/STAT

It took Anavex Life Sciences seven months to finally acknowledge the failure of a late-stage clinical trial in Rett syndrome.

The negative study outcome was never in doubt, so the only surprise from Tuesday’s announcement was the company’s lame attempt at damage control. Anavex is a serial dissembler of clinical trial results, so I was expecting better spin. Instead, management barely tried, which tells you the real results from the Rett study must be truly awful.

Anavex shares fell 31% to $6 in early trading. The company’s only drug in clinical development, called blarcamesine, is a zero. Rett is the latest failure, following earlier study failures in Alzheimer’s disease and Parkinson’s disease. Yet even with Tuesday’s drop in share price, Anavex still carries a fully diluted market value of nearly $650 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： NIH chief: government has fallen behind pharma on clinical trials

knowledge

WSS

FDA rejects Alnylam's heart disease treatment over insufficient data

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Was Amgen transparent enough on FDA's concern on cancer drug?

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Today's health inequities arise from racist U.S. history, say experts

focus

comprehensive

knowledge

Drug repurposing or repositioning? The language matters

The future of health care in the House

Moonlake's readout produced a cash windfall. Risks remain

Experimental asthma app from Apple and Anthem shows promise

DIEP, the 'gold standard' of breast reconstruction, is under threat

Publishing genetic code of viruses could cause disaster

Peter Hotez and the public health issue of online harassment

Carbon Health diabetes program, a test of data

United colonoscopy coverage change 'may cost lives,' doctors say

Ohio still needs to do more to protect the right to abortion

Wikipedia

What to expect at HLTH 2023, the health care industry conference

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Weight loss drugs should be covered by insurers, AMA says

VC firm General Catalyst wants to buy a health system

Bristol 'take

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Wikipedia

knowledge

Wikipedia

explore